1 unchanged sentence
(c) Trading Plans
−Removed: On July 15, 2024 , Dinesh V.
−Removed: Patel , our Chief Executive Officer and a member of our Board , terminated a trading plan intended to satisfy Rule 10b5-1(c) which he adopted on April 22, 2024 to sell up to 300,000 shares of the Company’s common stock through July 31, 2025, or such earlier date when all transactions under the trading plan were completed, subject to certain conditions.
−Removed: During the fiscal quarter ended September 30, 2024, no other director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case as defined in Item 408(a) of Regulation S-K).
+Added: During the fiscal quarter ended March 31, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement (in each case as defined in Item 408(a) of Regulation S-K).
EXHIBIT INDEX
20 unchanged sentences
PROTAGONIST THERAPEUTICS, INC.
−Removed: November 7, 2024
/s/ Dinesh V.
1 unchanged sentence
(Principal Executive Officer)
−Removed: November 7, 2024
Executive Vice President, Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.